Evaluation of the interactions of common genetic mutations in stroke.

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Stroke is a common entity. It is the third leading cause of death and the leading cause of adult disability in the developed world. More than 110 heritable disorders, more than 175 genetic loci, and more than 2050 unique mutations predisposing to stroke are known. Although ischemic stroke can result from merely one gene defect (and a number of clearly defined mendelian hereditary disorders do lead to stroke), the interaction of unfavorable genetic factors such as the Leiden V, methylenetetrahydrofolate reductase (MTHFR) 677TT, apolipoprotein E (ApoE) 4, and angiotensin-converting enzyme (ACE) D/D genotypes, which alone are not major risk factors, can in specific patterns exert a synergistic effect on certain clinical risk factors. This chapter discusses how to evaluate these interactions and the interpretation of findings.

Original languageEnglish
Pages (from-to)241-250
Number of pages10
JournalMethods in molecular medicine
Volume104
Publication statusPublished - 2005

Fingerprint

Stroke
Mutation
Apolipoprotein E4
Methylenetetrahydrofolate Reductase (NADPH2)
Genetic Loci
Peptidyl-Dipeptidase A
Cause of Death
Genotype
Genes

Cite this

Evaluation of the interactions of common genetic mutations in stroke. / Szolnoki, Z.

In: Methods in molecular medicine, Vol. 104, 2005, p. 241-250.

Research output: Contribution to journalArticle

@article{09a59b712bae443685cfdf155bc69678,
title = "Evaluation of the interactions of common genetic mutations in stroke.",
abstract = "Stroke is a common entity. It is the third leading cause of death and the leading cause of adult disability in the developed world. More than 110 heritable disorders, more than 175 genetic loci, and more than 2050 unique mutations predisposing to stroke are known. Although ischemic stroke can result from merely one gene defect (and a number of clearly defined mendelian hereditary disorders do lead to stroke), the interaction of unfavorable genetic factors such as the Leiden V, methylenetetrahydrofolate reductase (MTHFR) 677TT, apolipoprotein E (ApoE) 4, and angiotensin-converting enzyme (ACE) D/D genotypes, which alone are not major risk factors, can in specific patterns exert a synergistic effect on certain clinical risk factors. This chapter discusses how to evaluate these interactions and the interpretation of findings.",
author = "Z. Szolnoki",
year = "2005",
language = "English",
volume = "104",
pages = "241--250",
journal = "Methods in molecular medicine",
issn = "1543-1894",
publisher = "Humana Press",

}

TY - JOUR

T1 - Evaluation of the interactions of common genetic mutations in stroke.

AU - Szolnoki, Z.

PY - 2005

Y1 - 2005

N2 - Stroke is a common entity. It is the third leading cause of death and the leading cause of adult disability in the developed world. More than 110 heritable disorders, more than 175 genetic loci, and more than 2050 unique mutations predisposing to stroke are known. Although ischemic stroke can result from merely one gene defect (and a number of clearly defined mendelian hereditary disorders do lead to stroke), the interaction of unfavorable genetic factors such as the Leiden V, methylenetetrahydrofolate reductase (MTHFR) 677TT, apolipoprotein E (ApoE) 4, and angiotensin-converting enzyme (ACE) D/D genotypes, which alone are not major risk factors, can in specific patterns exert a synergistic effect on certain clinical risk factors. This chapter discusses how to evaluate these interactions and the interpretation of findings.

AB - Stroke is a common entity. It is the third leading cause of death and the leading cause of adult disability in the developed world. More than 110 heritable disorders, more than 175 genetic loci, and more than 2050 unique mutations predisposing to stroke are known. Although ischemic stroke can result from merely one gene defect (and a number of clearly defined mendelian hereditary disorders do lead to stroke), the interaction of unfavorable genetic factors such as the Leiden V, methylenetetrahydrofolate reductase (MTHFR) 677TT, apolipoprotein E (ApoE) 4, and angiotensin-converting enzyme (ACE) D/D genotypes, which alone are not major risk factors, can in specific patterns exert a synergistic effect on certain clinical risk factors. This chapter discusses how to evaluate these interactions and the interpretation of findings.

UR - http://www.scopus.com/inward/record.url?scp=16544382991&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16544382991&partnerID=8YFLogxK

M3 - Article

C2 - 15454671

AN - SCOPUS:16544382991

VL - 104

SP - 241

EP - 250

JO - Methods in molecular medicine

JF - Methods in molecular medicine

SN - 1543-1894

ER -